Xiao Lin Wang
Corporate Officer/Principal chez REVOLUTION MEDICINES, INC.
Profil
Xiao Lin Wang is currently the Executive Vice President-Development at Revolution Medicines, Inc. Prior to this role, she held the position of Vice President-Biometrics at Acerta Pharma LLC from 2015 to 2018.
Before that, she served as the VP-Biometrics & Development Operations at Geron Corp.
from 2010 to 2015.
Dr. Wang obtained a doctorate degree from Harvard University and an undergraduate degree from Peking University.
Postes actifs de Xiao Lin Wang
| Sociétés | Poste | Début |
|---|---|---|
| REVOLUTION MEDICINES, INC. | Corporate Officer/Principal | 01/03/2021 |
Anciens postes connus de Xiao Lin Wang
| Sociétés | Poste | Fin |
|---|---|---|
| Acerta Pharma LLC | Corporate Officer/Principal | 01/03/2018 |
| GERON CORPORATION | Corporate Officer/Principal | 01/05/2015 |
Formation de Xiao Lin Wang
| Harvard University | Doctorate Degree |
| Peking University | Undergraduate Degree |
| University of Washington | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| REVOLUTION MEDICINES, INC. | Health Technology |
| GERON CORPORATION | Health Technology |
| Entreprise privées | 1 |
|---|---|
| Acerta Pharma LLC |
